Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo-and Active-Comparator-Controlled Study of Etoricoxib 120 mg in the Treatment of Primary Dysmenorrhea

NCT00092729 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00092729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00092729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo-and Active-Comparator-Controlled Study of Etoricoxib 120 mg in the Treatment of Primary Dysmenorrhea
Lead sponsor
Organon and Co
Phase
Phase 3
Overall status
Completed
Start date
June 7, 2002
Completion date
December 6, 2002
Enrollment
129 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

dysmenorrhea